| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Auwaerter Paul Gisbert serves as a Director at CAPR. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $20K at current prices.
The biggest single holding is CAPR (~$20K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 5,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 6, 2023 | CAPR Capricor Therapeutics, Inc. | Director | Buy | 5,000 | $2.84 | $14,200.00 | New | +82.8% | +646.6% |